Developing novel blood-stage malaria vaccines
<p>Natural exposure to Plasmodium falciparum’s asexual blood-stage results in protection against severe disease, but no vaccine using the widely-studied blood-stage antigens apical membrane antigen 1 (AMA1) or merozoite surface protein 1 (MSP1) has proven convincingly protective in clinical tr...
第一著者: | Douglas, AD |
---|---|
その他の著者: | Draper, SJ |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2015
|
主題: |
類似資料
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
著者:: Kapulu, MC
出版事項: (2014) -
Enhancing the efficacy of viral vector blood-stage malaria vaccines
著者:: Forbes, E
出版事項: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
著者:: Elias, SC
出版事項: (2014) -
Liver-stage vaccines for malaria
著者:: Longley, RJ
出版事項: (2013) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
著者:: Bauza, K
出版事項: (2012)